Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/15/2017 02/16/2017 02/17/2017 02/21/2017 02/22/2017 Date
117.31(c) 116.32(c) 116.87(c) 117.17(c) 116.9(c) Last
1 160 216 1 490 726 1 220 881 1 495 848 1 326 849 Volume
+0.11% -0.84% +0.47% +0.26% -0.23% Change
More quotes
Financials ($)
Sales 2017 7 886 M
EBIT 2017 2 525 M
Net income 2017 1 165 M
Debt 2017 9 260 M
Yield 2017 0,84%
Sales 2018 8 149 M
EBIT 2018 2 686 M
Net income 2018 1 552 M
Debt 2018 8 156 M
Yield 2018 0,92%
P/E ratio 2017 23,22
P/E ratio 2018 17,05
EV / Sales2017 4,15x
EV / Sales2018 3,88x
Capitalization 23 469 M
More Financials
Company
Zimmer Biomet Holdings, Inc. designs, manufactures and markets orthopaedic reconstructive products; sports medicine, extremities and trauma products; craniomaxillofacial and thoracic products; dental implants; and related surgical products.It operates through three major geographic segments:... 
More about the company
Surperformance© ratings of Zimmer Biomet Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ZIMMER BIOMET HOLDINGS INC
02/16 ZIMMER BIOMET : Announces the International Release of the Innovative Subchondro..
02/10 ZIMMER BIOMET : slicing 1% of its US jobs Warsaw company mum on actual number to..
02/09 ZIMMER BIOMET : Technical Reports on Medical Equipment Equities -- Edwards Lifes..
02/09 Smith & Nephew hurt by tough markets in China and Gulf states
02/07 ZIMMER BIOMET : Feb 7, 2017 Zimmer Biomet Announces the International Release of..
02/07 ZIMMER BIOMET : Feb 7, 2017 Zimmer Biomet Holdings to Present at the LEERINK Par..
02/01 ZIMMER BIOMET : Feb 1, 2017 Zimmer Biomet Announces FDA Approval of Expanded 26-..
01/31DJZIMMER BIOMET : Hip, Knee Businesses Drive Results
01/31 ZIMMER BIOMET : beats 4Q profit forecasts
01/31 ZIMMER BIOMET HOLDINGS, INC. : Results of Operations and Financial Condition, Fi..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/21DJMEDTRONIC : Earnings Fall, Sales Rise -- Update
02/21 MEDTRONIC : sales, profit beat estimates; shares rise
02/21DJMEDTRONIC : Earnings Fall, Sales Rise
02/16 STRAUMANN : on hunt for 3D printer partner, could take stake - CEO
02/09 Smith & Nephew hurt by tough markets in China and Gulf states
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
02/17Zimmer Biomet Holdings's strong-buy rating reiterated at Needham & Compan.. 
02/16Comprehensive Reverse Shoulder by Zimmer Biomet: Class I Recall - High Fractu..
1
02/15BRIEF-U.S. FDA - Zimmer Biomet recalls comprehensive reverse shoulder due to .. 
02/15Pitcairn Co. Increases Position in Zimmer Biomet Holdings, Inc. $ZBH  
02/14Radnor Capital Management LLC Purchases Shares of 2,333 Zimmer Biomet Holding.. 
More tweets
Qtime:29
News from SeekingAlpha
02/13 DIVIDEND CHALLENGERS (AND NEAR-CHALL : 87 Increases Expected By April 30
02/09 VALUATION DASHBOARD : Healthcare - Update
01/31 Zimmer Biomet Holdings' (ZBH) CEO David Dvorak on Q4 2016 Results - Earnings ..
01/31 Zimmer Biomet Holdings revenues up 4%; non-GAAP EPS up 2% in Q4; updates 2017..
01/31 Zimmer Biomet beats by $0.03, beats on revenue
Advertisement
Chart ZIMMER BIOMET HOLDINGS INC
Duration : Period :
Zimmer Biomet Holdings Inc Technical Analysis Chart | ZBH | US98956P1021 | 4-Traders
Full-screen chart
Technical analysis trends ZIMMER BIOMET HOL...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 134 $
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David C. Dvorak President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Robin T. Barney Senior VP-Global Operations & Logistics
Daniel P. Florin Chief Financial Officer & Senior Vice President
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS..13.54%23 469
MEDTRONIC PLC13.10%110 613
BAXTER INTERNATIONAL I..12.67%27 174
C R BARD INC8.27%17 521
HOYA CORPORATION3.01%17 432
DENTSPLY SIRONA INC8.26%14 430
More Results